|
|
Name: |
venBio Select Advisor LLC |
City: |
San Francisco |
State: |
CA |
Zip: |
94158 |
|
|
|
Achive
data |
View
Filing Period: |
|
|
|
|
|
|
Download |
|
|
|
|
|
Free Registration Required For Full Results
|
|
|
Holdings
Found :
53 |
|
View All Holdings |
Currently
Viewing:
ALL |
|
|
Page 1 of 1 |
Menu
|
Ticker |
Company Name |
Position Rank |
New/Closed Postion |
Last Close |
Value |
Shares Held |
% of Portfolio |
Value Change |
Change In Shares Held |
% of Company |
Industry |
|
UTHR |
United Therapeutics Corp |
1 |
- |
$272.88 |
$656,744,000 |
2,858,888 |
7.66% |
28,103,000 |
0 |
6.049 |
Drug Manufacturers - ... |
|
APLS |
Apellis Pharmaceuticals Inc |
2 |
- |
$40.61 |
$653,111,000 |
11,111,111 |
7.62% |
-12,000,000 |
0 |
9.707 |
N/A |
|
ASND |
Ascendis Pharma AS |
3 |
- |
$130.41 |
$599,641,000 |
3,966,666 |
6.99% |
126,629,000 |
211,111 |
6.138 |
N/A |
|
SRPT |
Sarepta Therapeutics Inc |
4 |
- |
$123.46 |
$562,432,000 |
4,344,444 |
6.56% |
143,497,000 |
0 |
5.16 |
Drug Manufacturers - ... |
|
MDGL |
Madrigal Pharmaceuticals Inc |
5 |
- |
$229.58 |
$519,244,000 |
1,944,444 |
6.06% |
82,193,000 |
55,556 |
9.85 |
Diagnostic Substances |
|
ARGX |
Argenx Se |
6 |
- |
$367.07 |
$487,609,000 |
1,238,467 |
5.69% |
17,943,000 |
3,900 |
2.634 |
N/A |
|
KRYS |
Krystal Biotech Inc |
7 |
- |
$162.83 |
$454,710,000 |
2,555,555 |
5.3% |
136,427,000 |
-10,000 |
10.259 |
N/A |
|
XBI |
streetTRACKS Series Trust S... |
8 |
- |
$88.83 |
$408,027,000 |
4,300,000 |
4.76% |
11,183,000 |
-144,444 |
0.817 |
Closed - End Fund - E... |
|
BMRN |
Biomarin Pharmaceutical Inc |
9 |
- |
$88.63 |
$381,239,000 |
4,365,000 |
4.45% |
-33,367,000 |
65,000 |
2.317 |
Drug Manufacturers - ... |
|
FOLD |
Amicus Therapeutics Inc |
10 |
- |
$10.61 |
$322,772,000 |
27,400,000 |
3.76% |
-66,034,000 |
0 |
8.054 |
Biotechnology |
|
CERE |
Cerevel Therapeutics Holdin... |
11 |
- |
$41.33 |
$319,373,000 |
7,555,555 |
3.73% |
-983,000 |
0 |
4.833 |
N/A |
|
VKTX |
Viking Therapeutics, Inc. |
12 |
New |
$62.75 |
$294,380,000 |
3,590,000 |
3.43% |
294,380,000 |
3,590,000 |
3.573 |
N/A |
|
ARWR |
Arrowhead Pharmaceuticals Inc |
13 |
- |
$24.88 |
$244,689,000 |
8,555,555 |
2.85% |
210,111,000 |
7,425,555 |
8.364 |
Business Services |
|
XENE |
Xenon Pharmaceuticals Inc. |
14 |
- |
$0.00 |
$243,950,000 |
5,666,666 |
2.85% |
-17,057,000 |
0 |
7.527 |
N/A |
|
ALPN |
Alpine Immune Sciences Inc |
15 |
New |
$64.97 |
$228,921,000 |
5,775,000 |
2.67% |
228,921,000 |
5,775,000 |
8.811 |
N/A |
|
VERA |
Vera Therapeutics, Inc. |
16 |
New |
$0.00 |
$227,027,000 |
5,265,000 |
2.65% |
227,027,000 |
5,265,000 |
12.434 |
N/A |
|
IOVA |
Iovance Biotherapeutics Inc |
17 |
- |
$10.01 |
$173,394,000 |
11,700,000 |
2.02% |
118,923,000 |
5,000,000 |
5.471 |
N/A |
|
ITCI |
Intra Cellular Therapies Inc |
18 |
- |
$65.54 |
$171,270,000 |
2,475,000 |
2% |
9,727,000 |
219,445 |
2.622 |
N/A |
|
KYMR |
Kymera Therapeutics, Inc. |
19 |
- |
$0.00 |
$156,333,000 |
3,888,888 |
1.82% |
60,221,000 |
113,888 |
6.238 |
N/A |
|
RNA |
Avidity Biosciences, Inc. |
20 |
- |
$27.45 |
$148,654,000 |
5,825,000 |
1.73% |
125,938,000 |
3,315,000 |
7.326 |
N/A |
|
MLTX |
Multisys Language Solutions... |
21 |
- |
$0.00 |
$129,593,000 |
2,580,000 |
1.51% |
-26,213,000 |
0 |
4.304 |
N/A |
|
SNDX |
Syndax Pharmaceuticals Inc |
22 |
- |
$20.28 |
$100,489,000 |
4,222,222 |
1.17% |
9,247,000 |
0 |
4.491 |
N/A |
|
MGNX |
Macrogenics Inc |
23 |
New |
$4.55 |
$90,528,000 |
6,150,000 |
1.06% |
90,528,000 |
6,150,000 |
9.915 |
Biotechnology |
|
KURA |
Kura Oncology Inc |
24 |
- |
$21.17 |
$82,121,000 |
3,850,000 |
0.96% |
39,269,000 |
870,000 |
4.597 |
N/A |
|
AUTL |
Autolus Therapeutics Plc |
25 |
New |
$3.92 |
$78,765,000 |
12,345,678 |
0.92% |
78,765,000 |
12,345,678 |
7.134 |
N/A |
|
AGLE |
Aeglea Biotherapeutics, Inc. |
26 |
- |
$0.60 |
$69,759,000 |
1,839,138 |
0.81% |
30,181,000 |
0 |
3.007 |
N/A |
|
SLNO |
Soleno Therapeutics Inc |
27 |
- |
$0.16 |
$69,550,000 |
1,625,000 |
0.81% |
37,954,000 |
840,000 |
2.041 |
N/A |
|
BCRX |
Biocryst Pharmaceuticals Inc |
28 |
- |
$6.13 |
$66,294,000 |
13,050,000 |
0.77% |
-11,876,000 |
0 |
6.887 |
Biotechnology |
|
OCUL |
Ocular Therapeutix, Inc |
29 |
New |
$0.00 |
$65,055,000 |
7,148,936 |
0.76% |
65,055,000 |
7,148,936 |
6.486 |
N/A |
|
TSHA |
Taysha Gene Therapies, Inc. |
30 |
- |
$0.00 |
$53,526,000 |
18,650,000 |
0.62% |
45,817,000 |
14,294,445 |
9.975 |
N/A |
|
TRML |
Tourmaline Bio |
31 |
- |
$0.00 |
$50,889,000 |
2,222,222 |
0.59% |
28,154,000 |
1,353,815 |
5.379 |
N/A |
|
ROIV |
Roivant Sciences Ltd. |
32 |
- |
$10.98 |
$49,023,000 |
4,651,162 |
0.57% |
-3,210,000 |
0 |
0.672 |
N/A |
|
ALNY |
Alnylam Pharmaceuticals Inc |
33 |
- |
$147.76 |
$44,835,000 |
300,000 |
0.52% |
-167,843,000 |
-811,111 |
0.244 |
Biotechnology |
|
MNKD |
MannKind Corp |
34 |
- |
$4.78 |
$40,770,000 |
9,000,000 |
0.48% |
8,010,000 |
0 |
3.869 |
Biotechnology |
|
MRUS |
Merus Nv |
35 |
- |
$59.99 |
$40,027,000 |
888,888 |
0.47% |
15,583,000 |
0 |
1.54 |
N/A |
|
PCVX |
Vaxcyte, Inc. |
36 |
New |
$0.00 |
$39,278,000 |
575,000 |
0.46% |
39,278,000 |
575,000 |
0.533 |
N/A |
|
RARE |
Ultragenyx Pharmaceutical Inc |
37 |
- |
$40.34 |
$38,753,000 |
830,000 |
0.45% |
22,016,000 |
480,000 |
1.011 |
Restaurants |
|
MRNS |
Marinus Pharmaceuticals Inc |
38 |
- |
$1.38 |
$37,431,000 |
4,140,607 |
0.44% |
3,190,000 |
990,607 |
7.438 |
N/A |
|
RCKT |
Rocket Pharmaceuticals |
39 |
- |
$21.42 |
$33,969,000 |
1,260,900 |
0.4% |
-3,820,000 |
0 |
1.362 |
N/A |
|
GLUE |
Monte Rosa Therapeutics, Inc. |
40 |
- |
$0.00 |
$31,972,000 |
4,535,000 |
0.37% |
6,349,000 |
0 |
10.193 |
N/A |
|
CGON |
CG Oncology, Inc |
41 |
New |
$32.71 |
$30,730,000 |
700,000 |
0.36% |
30,730,000 |
700,000 |
1.061 |
N/A |
|
CRSP |
Crispr Therapeutics Ag |
42 |
New |
$55.24 |
$28,599,000 |
419,580 |
0.33% |
28,599,000 |
419,580 |
0.594 |
N/A |
|
VRCA |
Verrica Pharmaceuticals Inc. |
43 |
- |
$8.56 |
$23,680,000 |
3,999,999 |
0.28% |
-5,600,000 |
0 |
15.564 |
N/A |
|
KYTX |
Kyverna Therapeutics |
44 |
New |
$13.00 |
$11,799,000 |
475,000 |
0.14% |
11,799,000 |
475,000 |
1.105 |
N/A |
|
AADI |
Aadi Bioscience, Inc |
45 |
- |
$1.84 |
$6,668,000 |
2,849,402 |
0.08% |
912,000 |
0 |
13.64 |
N/A |
|
ADVM |
Adverum Biotechnologies, Inc |
46 |
New |
$7.60 |
$5,892,000 |
416,666 |
0.07% |
5,892,000 |
416,666 |
0.413 |
N/A |
|
CBAY |
Cymabay Therapeutics, Inc. |
52 |
Closed |
$32.48 |
$0 |
0 |
0% |
-262,444,000 |
-11,111,111 |
0 |
N/A |
|
NUVL |
Nuvalent, Inc. |
48 |
Closed |
$0.00 |
$0 |
0 |
0% |
-13,167,000 |
-178,921 |
0 |
N/A |
|
MRTX |
Mirati Therapeutics, Inc. |
51 |
Closed |
$58.70 |
$0 |
0 |
0% |
-287,102,000 |
-4,886,840 |
0 |
Biotechnology |
|
FENC |
Fennec Pharmaceuticals Inc |
50 |
Closed |
$6.70 |
$0 |
0 |
0% |
-13,464,000 |
-1,200,000 |
0 |
Home Health Care |
|
GPCR |
Structure Therapeutics Inc. |
47 |
Closed |
$37.06 |
$0 |
0 |
0% |
-95,107,000 |
-2,333,333 |
0 |
N/A |
|
IMGN |
Immunogen Inc |
53 |
Closed |
$31.23 |
$0 |
0 |
0% |
-25,944,000 |
-875,000 |
0 |
Drug Manufacturers - ... |
|
KRTX |
Karuna Therapeutics, Inc. |
49 |
Closed |
$0.00 |
$0 |
0 |
0% |
-39,564,000 |
-125,000 |
0 |
N/A |
|